טוען...
Therapy of chronic hepatitis C in people who inject drugs: focus on adherence
BACKGROUND: Intravenous drug use (IVDU) represents the major factor of HCV transmission, but the treatment uptake among people who inject drugs (PWID) remains low owing to a false presumption of low efficacy. The aim of our study was to assess treatment efficacy in PWID and factors determining adher...
שמור ב:
| הוצא לאור ב: | Harm Reduct J |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8247095/ https://ncbi.nlm.nih.gov/pubmed/34193156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12954-021-00519-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|